Skin sensitivity: an emerging signal Skin burning and abnormal touch sensitivity (dysesthesia) appears as a dose-related, reversible signal in two case series and post-market surveillance. Trials did not pre-specify it, and the tirzepatide label does not list it
They are not intended for human use and have not been evaluated by the FDA for diagnosing, treating, curing, or preventing any disease
This would result in relatively higher estrogen levels in proportion to progesterone
For patients with chronic gut inflammation, IBD, or autoimmune skin conditions who have not found adequate resolution through existing approaches, KPV warrants a serious clinical conversation not as a replacement for current care, but as a precisely targeted addition to a supervised protocol
Subcutaneous fat surrounding the knee provides adequate proximity for peptide diffusion to deeper structures
Look for third-party testing showing greater than 98% purity, preferably 99% or higher